Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2000 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Applicant: Astrazeneca

« Back to Dashboard

Summary for Applicant: Astrazeneca

Patents:47
Tradenames:74
Ingredients:66
NDAs:161
Drug Master File Entries: (click here to view)5
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Astrazeneca
NAROPIN
ropivacaine hydrochloride monohydrate
Injectable; Injection020533Sep 24, 1996RXYes<disabled><disabled>
Astrazeneca Pharms
TENORMIN
atenolol
Injectable; Injection019058Sep 13, 1989RXYes<disabled><disabled>
Astrazeneca Pharms
HIBISTAT
chlorhexidine gluconate
Solution; Topical018300Approved prior to Jan 1, 1982OTCYes<disabled><disabled>
Astrazeneca
ISOETHARINE HCL
isoetharine hydrochloride
Solution; Inhalation089616Jun 13, 1991RXYes<disabled><disabled>
Astrazeneca
FENTANYL CITRATE AND DROPERIDOL
droperidol; fentanyl citrate
Injectable; Injection072028Apr 13, 1989DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
This search can help find similar names.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc